- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 69-83 of
169 results
1056 Exhibit: 21 CFR 300 499 as of April 1, 2001
Document
IPR2018-01714, No. 1056-60 Exhibit - 21 CFR 300 499 as of April 1, 2001 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1001 Exhibit: US Patent No 7,968,569 the 569 patent
Document
IPR2018-01714, No. 1001 Exhibit - US Patent No 7,968,569 the 569 patent (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1057 Exhibit: Lotus Pharmaceutical Co, Ltd and Alvogen Pine Brook LLCs First Set...
Document
IPR2018-01714, No. 1057-61 Exhibit - Lotus Pharmaceutical Co, Ltd and Alvogen Pine Brook LLCs First Set of Requests for Admission Nos 1 3 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1023 Exhibit: Koo et al, Vancomycin induced neutropenia, Drug Intell Clin Pharm, 2...
Document
IPR2018-01714, No. 1023-23 Exhibit - Koo et al, Vancomycin induced neutropenia, Drug Intell Clin Pharm, 2010780 782 1986 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1013 Exhibit: Celgene Corp, Press Release, August 28, 2001
Document
IPR2018-01714, No. 1013-13 Exhibit - Celgene Corp, Press Release, August 28, 2001 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1019 Exhibit: Jacobs et al, Prednisone in MOPP chemotherapy for Hodgkins disea...
Document
IPR2018-01714, No. 1019-19 Exhibit - Jacobs et al, Prednisone in MOPP chemotherapy for Hodgkins disease, Br Med J, 21469 1471 1976 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1054 Exhibit: Affidavit of Christopher Butler, Internet Archive
Document
IPR2018-01714, No. 1054-54 Exhibit - Affidavit of Christopher Butler, Internet Archive (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1033 Exhibit: Marisavljevic et al, Results of treatment of patients with advanced mu...
Document
IPR2018-01714, No. 1033-33 Exhibit - Marisavljevic et al, Results of treatment of patients with advanced multiple myeloma with the vincristine adriamycin dexamethasone protocol, Srp Arh Celok...
|
|
Cite Document
1038 Exhibit: Lacy, MQ, et al, Long term Results of Response to Therapy, Time to P...
Document
IPR2018-01714, No. 1038-38 Exhibit - Lacy, MQ, et al, Long term Results of Response to Therapy, Time to Progression, and Survival With Lenalidomide Plus Dexamethasone in Newly Diagnosed...
|
|
Cite Document
1058 Exhibit: Lotus Pharmaceutical Co, Ltd and Alvogen Pine Brook LLCs First Set...
Document
IPR2018-01714, No. 1058-62 Exhibit - Lotus Pharmaceutical Co, Ltd and Alvogen Pine Brook LLCs First Set of Interrogatories Nos 1 31 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1031 Exhibit: Moreira et al, Thalidomide exerts its inhibitory action on tumor necros...
Document
IPR2018-01714, No. 1031-31 Exhibit - Moreira et al, Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation, J Exp Med, 1771675 1680 1993 (P.T...
|
|
Cite Document
1047 Exhibit: Palmer et al, Dose Intensity Analysis of Melphalan and Prednisone in...
Document
IPR2018-01714, No. 1047-47 Exhibit - Palmer et al, Dose Intensity Analysis of Melphalan and Prednisone in Multiple Myeloma J Natl Cancer Inst, 80414 418 1988 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1012 Exhibit: Celgene Corp, Press Release, May 8, 2001
Document
IPR2018-01714, No. 1012-12 Exhibit - Celgene Corp, Press Release, May 8, 2001 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1026 Exhibit: Revlimid Label
Document
IPR2018-01714, No. 1026-26 Exhibit - Revlimid Label (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1018 Exhibit: Enzinger et al, Phase II clinical trial of 13 cis retinoic acid and interfer...
Document
IPR2018-01714, No. 1018-18 Exhibit - Enzinger et al, Phase II clinical trial of 13 cis retinoic acid and interferon ¿¿ 2a in patients with advanced esophageal carcinoma, Cancer, 851213 1217 1999...
|
|
Cite Document
